NervePro Research

Irvine, California 92618

0 studies enrolling now · 6 studies all time

What they study most

Alzheimer's Disease, Chronic Pain, Fibromyalgia, Mild Cognitive Impairment, Multiple Sclerosis, Relapsing-Remitting, Osteoarthritis

Studies at this site

• A Phase II Study Comparing Low- and High-Dose Alemtuzumab and High-Dose Rebif® in Patients With Early, Active Relapsing-Remitting Multiple Sclerosis — Completed
• A 28-Week Open Label Extension Study Evaluating Safety and Tolerability of Donepezil Hydrochloride in Subjects With Mild Cognitive Impairment — Completed
• A Study of Embeda (Kadian NT, ALO-01) in Subjects With Pain Due to Osteoarthritis of the Hip or Knee — Completed
• Safety and Efficacy Study of Xyrem® (Sodium Oxybate) in Subjects With Fibromyalgia. — Completed
• A Safety and Efficacy Study of Xyrem® (Sodium Oxybate) to Treat Fibromyalgia. — Completed
• SGS742 in Patients With Mild to Moderate Alzheimer's Disease (AD) — Completed